LATEST FROM THE BLOG:
2020 is in the rearview mirror as the year no one was prepared for. During COVID, Prelude to a Cure (Prelude/P2AC) found itself at odds with our mission and goal with the need to be safe and socially distant from each other. Though, we were not idle. The Board of Prelude took a look at ourselves and realized we had room for improvement to redefine ourselves so that you know exactly who we are, what we do, how to get involved, give and see the research we’ve funded.
Prelude began 8 years ago with the determination to provide critical funding for the least funded of the major cancers; lung cancer. Our focus remains unique in that our purpose to provide “seed grants” for young investigators is more vital and in demand. These ideas at their emergent stage become the new ideas that can grow into world changing discoveries. For you; our family, friends, donors, supporters, patients/survivors and caregivers it means that together, we have work to do. Yes, we’re the elephant in the room, the one cancer that evokes many strong emotions and reactions which have become a part of our unconscious bias.Read more…
Our Twitter feed
Living with cancer can be confusing. When you’re talking to your doctor, caregiver, or friends, you may hear words that you don’t understand. Learning these common cancer words may help you better understand your diagnosis: https://t.co/EaWBNjqsu4. https://t.co/U7CqNV1ChG
Lung cancer has had improving outcomes, particularly attributable to immunotherapy. But how do we continue that trend? T-cell therapy, which transplants genetically engineered white cells known to specifically attack cancer cells, might be the answer. https://t.co/HK7VOWWKos
Whether you’re a researcher, a nurse, a CPA, a pro golfer, or anything else, YOU are part of finding a cure for lung cancer. We would like you to join us. Your contribution can be through science, funding, or participation. Learn more at https://t.co/wCMZ430mUk. #Tampa #StPete https://t.co/q0purBXioQ